Market cap comparisons. I own ARTH and like the st

Market cap comparisons. I own ARTH and like the stock. It has ONE product in development, a better surgical glue (and being developed for other wound care). The FDA made them do an additional safety study, and a couple days ago they announced that they were 2/3 of the way through it and felt optimistic.

Market cap, one product in clinical trials with an FDA request for more information: ARTH -- 87.5 million.

IPIX has had multiple successful clinical trials for 3 drugs with multiple different indications. No nasty letters from FDA. Market cap IPIX: 55.833 million.

Do you see how utterly ludicrous Patrick Cox's claim is about fears of stock dilution? A company that doesn't have its ONE product ready to go, and which faces stiff competition from a big pharma that is developing a similar product, has a market cap half again as big as IPIX's.

There is PLENTY of room to go up. A market cap 10 times what we have right now would be appropriate.

Ask yourself why Cox pumped IPIX and other stocks for so long, and then suddenly has said "sell." Ask yourself what his track record is.

I hope any subscribers will think about whether they trust what he has to say, given his horrendous track record.